Switching to investigational once-weekly insulin icodec from o...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
BAGSVAERD, Denmark, Sept. 22, 2020 /PRNewswire-AsiaNet/-- Today, Novo Nordisk announced results from three phase 2 clinical trials for insulin icodec, an investigational once-weekly basal insulin analogue, which were presented during the 56th European Association for the Study of Diabetes (EASD) Annual M...
Authors: LATEST ASIANET NEWS RELEASES